Search

everythinglearnresearchcommunity

for

Search:↓

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

SHBG may be a useful early indicator and treatment target for PCOS.

Multiple treatments work best for hair loss.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

A gene called HDAC9 might be a new factor in male-pattern baldness.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

RU 58841 may treat acne, hair loss, and excessive hair growth.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Genetics play a role in acne, but how exactly they contribute is not fully understood.